Company
Investment-firm
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
Also Known As
founded date
founders
Number of employees
IPO status
Contacts
Similar Companies999
Galen Partners
Galen Partners is a leading healthcare venture capital firm based in Stamford, Connecticut.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Vivo Capital
Vivo Capital is a global investment firm focused on healthcare, with approximately $5.8 billion in assets under management.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
CW Ventures
CW Group is a leading manager of medical venture capital funds focused on seed and early stage healthcare investing.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Brandon Capital Partners
Brandon Capital Partners is an Australian fund management business specializing in life science investments.
Sector
Subsector
Location
count Of Investments
count Of Exists
Financials
Investments555
Exsilio Therapeutics
Exsilio develops genomic therapeutics that introduce therapeutic genes into safe shelters within the DNA.
total rounds
total raised
Disc Medicine
Disc Medicine is a biopharmaceutical company developing therapies for hematologic diseases.
Sector
Subsector
Location
total rounds
total raised
Corvus Pharmaceuticals
Corvus Pharmaceuticals is developing drugs and antibodies that target critical elements of the immune system.
Sector
Subsector
Keywords
Location
total rounds
total raised
Co-Investors
Acquisitions1
Response Biomedical acquired by OrbiMed
acquirer
date
type
price
Response Biomedical
Response Biomedical Corp develops, manufactures and markets rapid diagnostic tests on the RAMPĀ® Platform.
Sector
Subsector
Location
total rounds
total raised
Exits82
Aduro BioTech
Aduro BioTech develops and sells therapies that use the body's immune system to treat diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
ARYx Therapeutics
ARYx is a pharmaceutical company specializing in retrometabolic drug design, enhancing the safety of oral therapies for chronic diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
Acceleron Pharma
Acceleron Pharma develops and sells biotherapeutics for musculoskeletal, metabolic, and cancer diseases.
Sector
Subsector
Location
total rounds
total raised
People
Founders2
Sam Isaly
Samuel D. Isaly is Managing Partner and Founder of Exome Asset Management. Sam Isaly is an experienced healthcare fund manager and has been active in global healthcare investing and analysis for over 45 years. Over the course of his career, Sam has been a pharmaceutical analyst with Chase Manhattan Bank, Merrill Lynch, Legg Mason, and S.G. Warburg. In 1989, Sam launched OrbiMed Advisors LLC. During his time at OrbiMed, Sam was the portfolio manager of Worldwide Healthcare Trust Plc for 22 years. Sam received an A.B. in Economics from Princeton University and a M.Sc. (Economics) from The London School of Economics.
current job
count Of Investments
Sam Isaly
Michael B. Sheffery
Michael B. Sheffery, Ph.D., is a founding Partner of OrbiMed. Dr. Sheffery was formerly Head of the Laboratory of Gene Structure and Expression at Memorial Sloan-Kettering Cancer Center. He received both his Ph.D. in Molecular Biology and his B.A. in Biology from Princeton University. Dr. Sheffery joined Mehta and Isaly in 1996 as a Senior Analyst covering the biotechnology industry.
current job
Michael B. Sheffery
Employee Profiles120
Truse Pretto
Executive assistant and office manager
Activity
Recent News50
The graph reveals the ratio (%) of positive news articles in a chosen time range